KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Payables (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Payables for 17 consecutive years, with $20.5 billion as the latest value for Q4 2025.

  • Quarterly Payables rose 25.73% to $20.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.5 billion through Dec 2025, up 25.73% year-over-year, with the annual reading at $20.5 billion for FY2025, 25.73% up from the prior year.
  • Payables hit $20.5 billion in Q4 2025 for Johnson & Johnson, up from $16.0 billion in the prior quarter.
  • In the past five years, Payables ranged from a high of $27.9 billion in Q2 2023 to a low of $11.9 billion in Q2 2021.
  • Historically, Payables has averaged $16.7 billion across 5 years, with a median of $14.8 billion in 2022.
  • Biggest YoY gain for Payables was 104.97% in 2023; the steepest drop was 42.23% in 2023.
  • Year by year, Payables stood at $12.8 billion in 2021, then grew by 14.25% to $14.6 billion in 2022, then fell by 10.25% to $13.1 billion in 2023, then rose by 24.54% to $16.3 billion in 2024, then grew by 25.73% to $20.5 billion in 2025.
  • Business Quant data shows Payables for JNJ at $20.5 billion in Q4 2025, $16.0 billion in Q3 2025, and $21.0 billion in Q2 2025.